Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
153 EUR | +0.69% | +2.79% | +6.25% |
06/05 | Biocartis, Merck KGaA Expand Cancer Biomarker Testing Collaboration into MENA Region | MT |
06/05 | MERCK KGAA : Gets a Buy rating from UBS | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.25% | 71.18B | |
+13.33% | 9.23B | |
-13.75% | 5B | |
+41.51% | 4.46B | |
+4.51% | 3.95B | |
+21.63% | 2.44B | |
-15.23% | 2.54B | |
-25.12% | 2.36B | |
+19.51% | 2.18B | |
+5.11% | 1.67B |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Merck : Samsung Bioepis Team Up To Launch Arthritis Drug In Australia, Canada